Acquisition of Inv(16)(p13q22) in a blast crisis of chronic myeloid leukemia: case report
Med Clin (Barc). 2019 May 17;152(10):419-420.
doi: 10.1016/j.medcli.2018.08.013.
Epub 2018 Nov 2.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Hematología, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
- 2 Servicio de Hematología, Hospital de la Santa Creu i Sant Pau, Barcelona, España. Electronic address: mpratcorona@santpau.cat.
No abstract available
MeSH terms
-
Abnormal Karyotype
-
Adult
-
Antineoplastic Agents / therapeutic use
-
Blast Crisis / genetics*
-
Chromosome Inversion*
-
Chromosomes, Human, Pair 16 / ultrastructure*
-
Dasatinib / therapeutic use
-
Female
-
Humans
-
Imatinib Mesylate / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Oncogene Proteins, Fusion / genetics
-
Protein Kinase Inhibitors / therapeutic use
-
Translocation, Genetic
-
Trisomy
Substances
-
Antineoplastic Agents
-
CBFbeta-MYH11 fusion protein
-
Oncogene Proteins, Fusion
-
Protein Kinase Inhibitors
-
Imatinib Mesylate
-
Dasatinib